Association and evidence for linked recognition of type IV secretion system proteins VirB9-1, VirB9-2, and VirB10 in Anaplasma marginale

Infection and Immunity

Volumn 80, Issue 1, 2012, Pages 215-227

  Morse, Kaitlyn ^a   Norimine, Junzo ^a   Palmer, Guy H ^a   Sutten, Eric L ^a   Baszler, Timothy V ^a   Brown, Wendy C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL PROTEIN VIRD4; BACTERIUM PROTEIN VIRB10; BACTERIUM PROTEIN VIRB11; BACTERIUM PROTEIN VIRB2; BACTERIUM PROTEIN VIRB4-1; BACTERIUM PROTEIN VIRB4-2; BACTERIUM PROTEIN VIRB6-1; BACTERIUM PROTEIN VIRB7; BACTERIUM PROTEIN VIRB8-2; BACTERIUM PROTEIN VIRB9-1; BACTERIUM PROTEIN VIRB9-2; HLA DRB3 ANTIGEN; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CARRIER PROTEIN; HLA ANTIGEN CLASS 2; VIRULENCE FACTOR;

ANAPLASMA MARGINALE; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; CATTLE; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CELLULAR IMMUNITY; FEMALE; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOPRECIPITATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TYPE IV SECRETION SYSTEM; WESTERN BLOTTING; ANIMAL; BLOOD; FAR WESTERN BLOTTING; GENETICS; IMMUNOLOGY;

ANAPLASMA MARGINALE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOTTING, FAR-WESTERN; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; VIRULENCE FACTORS;

EID: 84857072349     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05798-11     Document Type: Article

References (63)

1. + T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale. J. Immunol. 174:6702- 6715.
2. Araujo FB, et al. 2008. IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu. Mem. Inst. Oswaldo Cruz 103:186 -190.
3. Atmakuri K, Cascales E, Christie PJ. 2004. Energetic components VirD4, VirB11 and VirB4 mediate early DNA transfer reactions required for bacterial type IV secretion. Mol. Microbiol. 54:1199 -1211.
4. Bao W, et al. 2009. Four VirB6 paralogs and VirB9 are expressed and interact in Ehrlichia chaffeensis-containing vacuole. J. Bacteriol. 191:278-286.
5. Beaupre CE, Bohne J, Dale EM, Binns AN. 1997. Interactions between VirB9 and VirB10 membrane proteins involved in movement of DNA from Agrobacterium tumefaciens into plant cells. J. Bacteriol. 179:78-89.
6. Bhattacharya D, Mecsas J, Hu LT. 2010. Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis. Vaccine 28:7683-7689.
7. Brayton KA, et al. 2005. Complete genome sequencing of Anaplasma marginale reveals that the surface is skewed to two superfamilies of outer membrane proteins. Proc. Natl. Acad. Sci. U. S. A. 102:844-849.
8. + T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains. Infect. Immun. 69:6853- 6862.
9. Brown WC, Rice-Ficht AC, Estes DM. 1998. Bovine type 1 and type 2 responses. Vet. Immunol. Immunopathol. 63:45-55.
10. + T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect. Immun. 66:5406-5413.
11. Cascales E, Christie PJ. 2004. Agrobacterium VirB10, an ATP energy sensor required for type IV secretion. Proc. Natl. Acad. Sci. U. S. A. 101:17228-17233.
12. Chan CS, Winstone TM, Turner RJ. 2008. Investigating protein-protein interactions by far-Westerns. Adv. Biochem. Eng. Biotechnol. 110:195-214.
13. Chandran V, et al. 2009. Structure of the outer membrane complex of a type IV secretion system. Nature 462:1011-1015.
14. Christie PJ, Atmakuri K, Krishnamoorthy V, Jakubowski S, Cascales E. 2005. Biogenesis, architecture, and function of bacterial type IV secretion systems. Annu. Rev. Microbiol. 59:451- 485.
15. Das A, Xie YH. 2000. The Agrobacterium T-DNA transport pore proteins VirB8, VirB9, and VirB10 interact with one another. J. Bacteriol. 182:758-763.
16. Felek S, Huang H, Rikihisa Y. 2003. Sequence and expression analysis of virB9 of the type IV secretion system of Ehrlichia canis strains in ticks, dogs, and cultured cells. Infect. Immun. 71:6063- 6067.
17. Fronzes R, et al. 2009. Structure of a type IV secretion system core complex. Science 323:266 -268.
18. Ge Y, Rikihisa Y. 2007. Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics. J. Bacteriol. 189:7819 -7828.
19. Gillespie JJ, et al. 2009. An anomalous type IV secretion system in Rickettsia is evolutionarily conserved. PLoS One 4:e4833.
20. Gillespie JJ, et al. 2010. Phylogenomics reveals a diverse Rickettsiales type IV secretion system. Infect. Immun. 78:1809 -1823.
21. Haake DA, et al. 1999. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect. Immun. 67:6572-6582.
22. Hines SA, McElwain TF, Buening GM, Palmer GH. 1989. Molecular characterization of Babesia bovis merozoite surface proteins bearing epitopes immunodominant in protected cattle. Mol. Biochem. Parasitol. 37:1-10.
23. Ivanov MI, et al. 2008. Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1 Yersinia pestis. Infect. Immun. 76:5181-5190.
24. Judd PK, Kumar RB, Das A. 2005. Spatial location and requirements for the assembly of the Agrobacterium tumefaciens type IV secretion apparatus. Proc. Natl. Acad. Sci. U. S. A. 102:11498 -11503.
25. Judd PK, Kumar RB, Das A. 2005. The type IV secretion apparatus protein VirB6 of Agrobacterium tumefaciens localizes to a cell pole. Mol. Microbiol. 55:115-124.
26. Khan AQ, Lees A, Snapper CM. 2004. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4 T cell help. J. Immunol. 172:532-539.
27. Kumar RB, Xie YH, Das A. 2000. Subcellular localization of the Agrobacterium tumefaciens T-DNA transport pore proteins: VirB8 is essential for the assembly of the transport pore. Mol. Microbiol. 36:608-617.
28. Lai EM, Chesnokova O, Banta LM, Kado CI. 2000. Genetic and environmental factors affecting T-pilin export and T-pilus biogenesis in relation to flagellation of Agrobacterium tumefaciens. J. Bacteriol. 182:3705-3716.
29. Lai EM, Kado CI. 1998. Processed VirB2 is the major subunit of the promiscuous pilus of Agrobacterium tumefaciens. J. Bacteriol. 180:2711-2717.
30. Lee TF, McNellis TW. 2008. Elimination of keratin artifact bands from Western blots by using low concentrations of reducing agents. Anal. Biochem. 382:141-143.
31. Leroith T, et al. 2005. Sequence variation and immunologic crossreactivity among Babesia bovis merozoite surface antigen 1 proteins from vaccine strains and vaccine breakthrough isolates. Infect. Immun. 73:5388-5394.
32. Lopez JE, et al. 2008. High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation. J. Immunol. Methods 332:129 -141.
33. Lopez JE, et al. 2007. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine. Infect. Immun. 75:2333-2342.
34. Lopez JE, et al. 2005. Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect. Immun. 73:8109-8118.
35. Macmillan H, et al. 2006. Analysis of the Anaplasma marginale major surface protein 1 complex protein composition by tandem mass spectrometry. J. Bacteriol. 188:4983- 4991.
36. Macmillan H, Norimine J, Brayton KA, Palmer GH, Brown WC. 2007. Physical linkage of naturally complexed bacterial outer membrane proteins enhances immunogenicity. Infect. Immun. 76:1223-1229.
37. Malek JA, et al. 2004. Protein interaction mapping on a functional shotgun sequence of Rickettsia sibirica. Nucleic Acids Res. 32:1059 -1064.
38. McGuire TC, Palmer GH, Goff WL, Johnson MI, Davis WC. 1984. Common and isolate-restricted antigens of Anaplasma marginale detected with monoclonal antibodies. Infect. Immun. 45:697-700.
39. Mitchison NA. 1971. The carrier effect in the secondary response to hapten-protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis. Eur. J. Immunol. 1:10 -17.
40. Mitchison NA. 1971. The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. Eur. J. Immunol. 1:18 -27.
41. Mitchison NA. 1971. The carrier effect in the secondary response to hapten-protein conjugates. V. Use of antilymphocyte serum to deplete animals of helper cells. Eur. J. Immunol. 1:68 -75.
42. Niu H, Rikihisa Y, Yamaguchi M, Ohashi N. 2006. Differential expression of VirB9 and VirB6 during the life cycle of Anaplasma phagocytophilum in human leucocytes is associated with differential binding and avoidance of lysosome pathway. Cell Microbiol. 8:523-534.
43. Noh SM, et al. 2008. Composition of the surface proteome of Anaplasma marginale and its role in protective immunity induced by outer membrane immunization. Infect. Immun. 76:2219 -2226.
44. + T-lymphocyte responses. Immunogenetics. 57:750 -762.
45. Ochs D. 1983. Protein contaminants of sodium dodecyl sulfatepolyacrylamide gels. Anal. Biochem. 135:470-474.
46. Palmer GH, Barbet AF, Davis WC, McGuire TC. 1986. Immunization with an isolate-common surface protein protects cattle against anaplasmosis. Science 231:1299 -1302.
47. Palmer GH, McElwain TF. 1995. Molecular basis for vaccine development against anaplasmosis and babesiosis. Vet. Parasitol. 57:233-253.
48. Palmer GH, McGuire TC. 1984. Immune serum against Anaplasma marginale initial bodies neutralizes infectivity for cattle. J. Immunol. 133:1010-1015.
49. Palmer GH, et al. 1988. Immunization of cattle with a 36-kilodalton surface protein induces protection against homologous and heterologous Anaplasma marginale challenge. Infect. Immun. 56:1526 -1531.
50. Palmer GH, Rurangirwa FR, Kocan KM, Brown WC. 1999. Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol. Today 15:281-286.
51. Park YH, et al. 2004. Characterization of lymphocyte subpopulations and major histocompatibility complex haplotypes of mastitis-resistant and susceptible cows. J. Vet. Sci. 5:29 -39.
52. Rosenstein NE, Perkins BA. 2000. Update on Haemophilus influenzae serotype b and meningococcal vaccines. Pediatr. Clin. N. Am. 47:337-352.
53. Sagulenko V, Sagulenko E, Jakubowski S, Spudich E, Christie PJ. 2001. VirB7 lipoprotein is exocellular and associates with the Agrobacterium tumefaciens T pilus. J. Bacteriol. 183:3642-3651.
54. Schmidt-Eisenlohr H, et al. 1999. Vir proteins stabilize VirB5 and mediate its association with the T pilus of Agrobacterium tumefaciens. J. Bacteriol. 181:7485-7492.
55. Sharif S, et al. 1998. Associations of the bovine major histocompatibility complex DRB3 (BoLA-DRB3) alleles with occurrence of disease and milk somatic cell score in Canadian dairy cattle. Anim. Genet. 29:185-193.
56. Sutten EL, et al. 2010. Anaplasma marginale type IV secretion system proteins VirB2, VirB7, VirB11, and VirD4 are immunogenic components of a protective bacterial membrane vaccine. Infect. Immun. 78:1314-1325.
57. Tebele N, McGuire TC, Palmer GH. 1991. Induction of protective immunity by using Anaplasma marginale initial body membranes. Infect. Immun. 59:3199 -3204.
58. Terradot L, et al. 2004. Biochemical characterization of protein complexes from the Helicobacter pylori protein interaction map: strategies for complex formation and evidence for novel interactions within type IV secretion systems. Mol. Cell Proteomics 3:809-819.
59. van Eijk MJ, Stewart-Haynes JA, Lewin HA. 1992. Extensive polymorphism of the BoLA-DRB3 gene distinguished by PCR-RFLP. Anim. Genet. 23:483- 496.
60. Vidotto MC, McGuire TC, McElwain TF, Palmer GH, Knowles DP, Jr. 1994. Intermolecular relationships of major surface proteins of Anaplasma marginale. Infect. Immun. 62:2940 -2946.
61. Vidotto MC, Venancio EJ, Vidotto O. 2008. Cloning, sequencing and antigenic characterization of rVirB9 of Anaplasma marginale isolated from Parana State, Brazil. Genet. Mol. Res. 7:460-466.
62. Wu Y, Li Q, Chen XZ. 2007. Detecting protein-protein interactions by Far Western blotting. Nat. Protoc. 2:3278 -3284.
63. Yokoyama WM. 1994. Production of monoclonal antibodies, p 2.5.2-2.5.17. In J. E. Coligan (ed), Current protocols in immunology, vol 1. Wiley Interscience, Inc, New York, NY.